Newsletter | September 5, 2019

09.05.19 -- Breast Cancer Organization Highlights Biosimilars

 
Featured Editorial
Breast Cancer Patient Organization Sets Sights On Biosimilars
 
By Anna Rose Welch, editor, Biosimilar Development

During our discussion, I learned more about this patient organization and its biosimilar education goals, as well as what type of information could be particularly helpful for the breast cancer patient community as we embrace the entrance of biosimilar oncology mAbs.

Asia Bioprocessing Capacity Trends: Overall Growth, But Cell Therapy Shortages Loom
 
By Vicky Qing XIA, BioPlan Associates, Inc.

Overall, the growth in Asia’s bioprocessing capacity, particularly in China, has been impressive, albeit from a low baseline. Capacity growth over the past five years has been over 20 percent annually. New facility construction and expansions reflect the demand for biologics for domestic consumption, while other facilities are beginning to develop manufacturing strategies for GMP production for major markets, with capacity involving commercial-scale stainless-steel and single-use bioreactors.

Industry Insights
Optimizing Process Efficiency In Upstream Manufacturing
White Paper | By Dr. Andreas Castan, GE Healthcare Life Sciences

Increasing the integration of upstream and downstream processing and moving toward increased automation results in greater optimization of process efficiency — a key goal for biopharma production.

The Benefits Of Flow Cytometry In Immuno-Oncology Research
Article | By Jennifer Ellis and Gunjan Choudhary, Bio-Rad Laboratories, Inc.

Flow cytometry introduces a powerful and versatile technology into studies, enabling in-depth analysis of cell signaling and behavior.

Sponsor
 

CPhI Conferences’ Biopharma Conclave, scheduled on September 26 and 27, 2019, at The St. Regis, Mumbai, will deliberate on varied aspects such as biologics, gene therapy, vaccines, biosimilars, biomanufacturing, intellectual property rights, commercialization, and marketing strategies in the biopharma domain. Meet top industry stalwarts to address all your burning issues in regard to the latest trends, key challenges, and strategies to launch quality drugs in the global arena. Register here now.

Connect With Biosimilar Development:
      Twitter